Company: AEMD
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001683168-25-008271
Chunk: 1

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 1
---
 shares issued and outstanding at March 31, 2025. 
     761  
     259 
  
    Additional paid-in capital 
     176,975,368  
     173,095,221 
  
    Accumulated other comprehensive loss 
     (26,377) 
     (17,133)
  
    Accumulated deficit 
     (171,203,775) 
     (167,954,817)

    Total stockholders’ equity 
     5,745,977  
     5,123,530 

    Total liabilities and stockholders’ equity 
    $7,323,090  
    $7,359,534 

The accompanying notes are an integral part
of these condensed consolidated financial statements.

 4 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Six Month Periods Ended September
30, 2025 and 2024

(Unaudited)

    Three Months  Ended  September 30,  2025  
    Three Months  Ended  September 30,  2024  
    Six Months  Ended  September 30,  2025  
    Six Months  Ended  September 30,  2024 
  
    OPERATING EXPENSES 

    Professional fees 
    $393,796  
    $570,845  
    $869,828  
    $1,184,927 
  
    Payroll and related expenses 
     594,611  
     1,372,899  
     1,175,611  
     2,627,701 
  
    General and administrative 
     521,423  
     958,375  
     1,256,781  
     1,709,228 
  
    Total operating expenses 
     1,509,830  
     2,902,119  
     3,302,220  
     5,521,856 
  
    OPERATING LOSS 
     (1,509,830) 
     (2,902,119) 
     (3,302,220) 
     (5,521,856)

    INTEREST  INCOME, NET 
     22,730  
     95,146